Adar Poonawalla

Photo: The Indian Express

SII Adar Poonawalla Speaks About Monkeypox Vaccine In India

As monkeypox cases are rising in India, the Serum Institute of India (SII) which manufactured the Covid-19 vaccine, spoke about the possibility of a monkeypox vaccine in India. SII CEO Adar Poonawalla said, "We are talking to Novovax. We really need to see whether there will be a lot of demand or whether in three to four months it fizzles out." Moreover, he ruled out manufacturing from scratch amid time issues.

Tue, 26 Jul 2022 - 05:44 PM / by Varsha Joshi

Tags: Monkeypox, vaccine, SII, Adar Poonawalla, Cases

Adar's Tweet to Elon.

Photo: Twitter

SII CEO Adar Poonawalla Suggests Elon Musk To Invest In India For Tesla Manufacturing

Serum Institute of India CEO Adar Poonawalla, on May 8, suggested Elon Musk to invest in India for Tesla manufacturing. Tagging the Tesla boss in the tweet, he wrote "do look at investing some of that capital in INDIA for high-quality large-scale manufacturing of @Tesla cars. I assure you this will be the best investment you'll ever make (sic).” Nitik Gadkari had earlier said that Musk was welcome to India.

Sun, 08 May 2022 - 06:23 PM / by Varun Das

Tags: Elon Musk, Adar Poonawalla, Serum Institute of India, Twitter, Tesla

Courtesy: Hindustan Times

Covid-19 vaccine

Photo: News 18

Covishield Vaccine Prices Slashed To Rs 225, Says Adar Poonawalla

Ahead of the nationwide booster dose COVID-19 vaccination drives, the SII CEO Adar Poonawalla slashed the prices of Covishield from Rs 600 to Rs 225.  On April 9, Poonawalla tweeted, "SII has decided to revise the price of COVISHIELD vaccine for private hospitals from Rs.600 to Rs 225 per dose". Notably, the GoI announced a booster dose for the 18+ population at private vaccination centers in India from… read-more

Sat, 09 Apr 2022 - 05:30 PM / by Varsha Joshi

Tags: SII, Adar Poonawalla, Covid-19 Vaccine, COVISHIELD, Booster Dose

Courtesy: The Times of India

Adar Poonwalla, SII CEO

Photo: The Guardian

SII Applies For Full Market Authorisation To Govt Of India

Adar Poonwalla, CEO of the Serum Institute of India (SII) applied for full market authorisation of its COVID-19 vaccine, Covishield, on December 31. "Supplies of Covishield vaccine in India, exceeded 1.25 billion doses. The Government of India now has enough data to allow full market authorisation," tweeted SII CEO. The application has been submitted to the Union Government and MoHFW. Besides, SII's Covishield also export vaccine doses to… read-more

Fri, 31 Dec 2021 - 06:38 PM / by Varsha Joshi

Tags: Serum Institute of India, Adar Poonawalla, Covishield vaccine, Indian Markets, Exports

Courtesy: News 18

SII CEO Adar Poonawalla

Photo: Hindustan Times

SII To Launch Covavax For Children In Mid 2022: Adar Poonawalla

The Serum Institute of India CEO Adar Poonawalla announced to launch COVID-19 vaccine against children (3+). Addressing an event at SII, on December 14, Poonawalla said, Covavax is an Indian made version of the US-based Novavax. It is currently under trial and is showing excellent results on children. If successful, Covavax will be launched by mid-2022 in India, protecting kids against the COVID-19 virus. 

Tue, 14 Dec 2021 - 07:09 PM / by Varsha Joshi

Tags: SII, Adar Poonawalla, Covavax, children, Covid-19

Courtesy: The Siasat Daily

SII to boost Covishield production upto 200 MIllion doses from October

Photo: BioSpectrum Asia

SII To Boost Covishield Production To 200 Million Doses From Oct

CEO of Serum Institute of India (SII), Adar Poonawalla addressed a virtual conference with Executive Chairperson of Biocon Biologics (BBL) Kiran Mazumdar Shaw to announce their strategic alliance on September 17. Reportedly, SII was looking to scale up its research facilities with BBL. Also, the alliance aims to increase the production of Covishield Vaccines from 160 million doses monthly to 200 million doses from October.

Sat, 18 Sep 2021 - 02:31 PM / by Muskan Arora

Tags: Covid-19, COVISHIELD, SII, Covid Vaccine, Biocon Biologics, Adar Poonawalla

Courtesy: The Indian Express

Covishield Vaccine

Photo: Moneycontrol

Switzerland Along With 8 EU Nations Clear Covishield For Travel Pass

Serum Institute of India's Covishield vaccine is cleared for a travel pass in eight EU nations- Austria, Germany, Slovenia, Greece, Estonia, Iceland, Ireland, Spain, and Switzerland. Amidst issues of Covishield's travel pass clearance, Adar Poonawalla, CEO of Serum Institute tweeted on June 28, "I have taken this up at the highest levels and hope to resolve this matter soon." In the past, EMA had cleared only four vaccines. 

Thu, 01 Jul 2021 - 04:59 PM / by Aditi Chavan

Tags: COVISHIELD, Serum Institute of India, Adar Poonawalla, European Union, Switzerland, travel pass

Courtesy: NDTV


Photo: NDTV

DCGI Approves SII's Request To Manufacture Sputnik V In India

The Drug Controller General of India on June 4 approved the Serum Institute of India's request to manufacture Russian COVID-19 vaccine Sputnik-V. Adar Poonawalla-owned organisation has been granted permission to examine, test and analyse the vaccine in India. SII CEO Poonawalla thanked the Ministry of External Affairs and POTUS Joe Biden for relaxing the restrictions on vaccine manufacture. For the production, SII will join hands with… read-more

Sat, 05 Jun 2021 - 09:25 AM / by Nikita Thakur

Tags: SII, Adar Poonawalla, Sputnik-V, Russia, Covid-19, Covid Vaccine

Courtesy: Zee Business

Adar Poonawalla.

Photo: Business Standard

Adar Poonawalla Sells His Stakes In Panacea Biotech For Rs 118 Cr

Adar Poonawalla on May 17 transferred his entire 5.15% stake in Panacea Biotech to his company Serum Institute of India for Rs 118 crore. In an open market transaction, Poonawalla sold 3.15 million shares of Panacea Biotech at Rs 373.85 each. SII was already holding 4.98% stake in Panacea, hence, this deal stretches the total stake to 10.13%. Panacea has reportedly collaborated with Bharat Biotech for Covaxin production.

Tue, 18 May 2021 - 01:19 PM / by Harsh Vardhan

Tags: SII, Adar Poonawalla, Panacea Biotech, Covaxin, Bharat biotech

Courtesy: The Economic Times

Adar Poonawalla

Photo: New York Times

Adar Poonawalla In Fortune's Greatest Leaders List; New Zealand PM No1

New Zealand PM Jacinda Ardern has been placed at the top of the Fortune’s world’s 50 greatest leaders list for successfully tackling COVID-19 in the country. Interestingly, the CEO of Serum Institute of India, Adar Poonawalla, also made it to the list for boosting vaccine production by 90% in India's COVID crisis. Other leaders in the list include Paypal CEO Daniel H Schulman, NBA Rescuers and Jessica Tan among others.

Sun, 16 May 2021 - 01:43 PM / by Neha Sanjeev

Tags: Fortune-500, Adar Poonawalla, Jacinda Ardern, World Leaders

Courtesy: News18